Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Endothelial dysfunction in coronary heart disease

G M McGorisk1, C B Treasure

  • 1Emory University School of Medicine, Division of Cardiology, Atlanta, GA 30322, USA.

Current Opinion in Cardiology
|July 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of cholesterol-lowering therapy on coronary endothelial vasomotor function in patients with coronary artery disease.

Circulation·2000
Same author

Computer errors in electrocardiography.

Clinical cardiology·1996
Same author

Performance standards and edge detection with computerized quantitative coronary arteriography. The Lovastatin Restenosis Trial Group.

The American journal of cardiology·1996
Same author

Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease.

The New England journal of medicine·1995
Same author

Usefulness of Holter monitoring for detecting myocardial ischemia in patients with nondiagnostic exercise treadmill test.

The American journal of cardiology·1993
Same author

The dysfunctional endothelium in heart failure.

Journal of the American College of Cardiology·1993
Same journal

An integrative approach to patient selection for mitral transcatheter edge-to-edge repair in secondary mitral regurgitation.

Current opinion in cardiology·2026
Same journal

Rebooting blood vessel repair: implications of the SEMA-VR CardioLink-15 trial.

Current opinion in cardiology·2026
Same journal

Advancements in wearable technology for heart failure patients.

Current opinion in cardiology·2026
Same journal

Minimally invasive approaches to coronary artery bypass grafting: techniques, current evidence, and future directions.

Current opinion in cardiology·2026
Same journal

Advances in artificial intelligence for the evaluation of mitral regurgitation.

Current opinion in cardiology·2026
Same journal

Role of nutritional interventions to reduce cardiometabolic disease burden in the community.

Current opinion in cardiology·2026
See all related articles

Atherosclerosis plaque rupture risk can be reduced by lowering lipid and macrophage content. Addressing endothelial dysfunction is crucial for preventing early-stage atherosclerosis and cardiovascular events.

Area of Science:

  • Cardiovascular Science
  • Pathology
  • Medical Research

Background:

  • Atherosclerosis involves plaque buildup in vessel walls, leading to lumen obstruction.
  • Vulnerable plaques, rich in lipids and macrophages, pose a higher rupture risk than stable lesions.

Purpose of the Study:

  • To explore strategies for stabilizing atherosclerotic plaques and reducing cardiovascular event risk.
  • To investigate the role of endothelial dysfunction in early atherosclerosis pathogenesis.

Main Methods:

  • Review of current hypotheses on atherosclerosis pathogenesis.
  • Analysis of findings from cholesterol-lowering and antithrombotic therapy trials.

Main Results:

  • Cholesterol-lowering interventions significantly reduce acute cardiac events.

Related Experiment Videos

  • Antithrombotic therapies can mitigate consequences of plaque rupture.
  • Endothelial dysfunction is a key early stage requiring further investigation.

    • Conclusions:

    • Reducing plaque lipid and macrophage content may stabilize vulnerable plaques.
    • Targeting endothelial dysfunction is essential for preventing atherosclerosis progression.
    • Combined approaches addressing plaque composition and endothelial health are vital for cardiovascular risk reduction.